Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
08/2008
08/28/2008WO2008103351A2 Heterocyclic aspartyl protease inhibitors
08/28/2008WO2008103277A2 Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
08/28/2008WO2008101979A1 Quinoxaline compounds and use thereof
08/28/2008WO2008101682A2 Iminipyridine derivatives and their uses as microbiocides
08/28/2008WO2008070041A3 Inhibitors of akt activity
08/28/2008WO2007087488A9 Indole sulfonamide modulators of progesterone receptors
08/28/2008US20080207904 Crystal structure; crystallization from mixture of solvent and pyridine
08/28/2008US20080207740 Small organic molecule regulators of cell proliferation
08/28/2008US20080207696 Phenacyl 2-Hydroxy-3-Diaminoalkanes
08/28/2008US20080207691 Metabolic disorders; antidiabetic agents; hypoglycemic agents; obesity; hypotensive agents
08/28/2008US20080207636 Using a benzmide compound; antidiabetic agents; obesity
08/28/2008US20080207616 Anticancer agents; for humans, animals
08/28/2008US20080207613 Selective Kinase Inhibitors
08/28/2008US20080207608 Stroke; antiinflammatory agents; sepsis; allograft; transplant rejection; antitumor agents; liver disorders; brain hemorrage; neurodegenerative diseases ; vision defects
08/28/2008US20080206812 Generation of recombinant adeno- associated virus particles; generate nutrient broth, inoculate with genetically engineered cells, propagate cells and vector, release vector, harvest viral particles
08/28/2008DE4345228B4 Selbstlade-Granatwerfer Self-loading grenade launcher
08/28/2008CA2679066A1 Hydroxylamine compounds and methods of their use
08/28/2008CA2678958A1 Heterocyclic aspartyl protease inhibitors
08/28/2008CA2677949A1 Iminipyridine derivatives and their uses as microbiocides
08/28/2008CA2676173A1 Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
08/28/2008CA2675884A1 Quinoxaline compounds and use thereof
08/27/2008EP1962354A1 Organic electroluminescence element material and organic electroluminescence element using same
08/27/2008EP1961750A1 Vla-4 inhibitory drug
08/27/2008EP1961748A2 2-hydroxy-3-heteroarylindole derivatives as GSK3 inhibitors
08/27/2008EP1961416A1 Medical use of inhibitors of glutaminyl and glutamate cyclases
08/27/2008EP1960395A1 Plasminogen activator inhibitor-1 inhibitors
08/27/2008EP1960390A1 Biaryl compounds useful as agonists of the gpr38 receptor
08/27/2008EP1960387A1 Isoquinoline et benzo[h]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of histamine h3 receptor
08/27/2008EP1960386A2 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
08/27/2008EP1960370A1 Pyridiazinone derivatives for tumour treatment
08/27/2008EP1960368A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
08/27/2008EP1960363A2 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
08/27/2008EP1960359A1 Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions
08/27/2008EP1960355A1 3-amino-1-arylpropyl indoles and aza-substituted indoles
08/27/2008EP1960347A2 17-beta-hydroxysteroid dehydrogenase type 3 (17beta-hsd3) inhibitors
08/27/2008EP1959959A2 Morpholine carboxamide prokineticin receptor antagonists
08/27/2008EP1620431B1 3-carbonylaminothiophenes and their use as fungicides
08/27/2008EP1368325B1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
08/27/2008EP0952832B1 Quinoline carboxamides as tnf inhibitors and as pde-iv inhibitors
08/27/2008CN101253167A Substituted imidazole compounds as KSP inhibitors
08/27/2008CN101253166A Sulfonamide compound
08/27/2008CN101253153A 6-substituted-2,3,4,5-tetrahydro-1H-benzo[d] azepines as 5-HT2c receptor agonists
08/27/2008CN101253152A Amide derivatives as ROCK inhibitors
08/27/2008CN100413882C Linear basic compounds having nk-2 antagonist activity and formulations thereof
08/27/2008CN100413861C Compounds and methods for the treatment or prevention of flavivirus infections
08/27/2008CN100413859C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing same
08/26/2008US7417152 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring
08/26/2008US7417150 Azoles having an insecticidal action
08/26/2008US7417057 insecticides; safe for crops; Fused partially unsaturated carbocyclic or heterocyclic ring substituted with a 5-or 6-membered heterocyclic ring such as imidazole, thiazole, oxazole, 1,3,4-oxadiazole
08/26/2008CA2532743C Intermediates for preparing dialkyl-halogenophenyl-substituted ketoenols
08/26/2008CA2432129C Pyrazole compounds useful as protein kinase inhibitors
08/26/2008CA2329230C A process for the manufacture of sulfonylaminocarbonyl triazolinones in the presence of xylene as solvent
08/26/2008CA2274825C Substituted nitrogen containing heterocycles as inhibitors of p38 protein kinase
08/21/2008WO2008100867A2 Novel inhibitors hepatitis c virus replication
08/21/2008WO2008100809A1 Gamma-lactams for the treatment of glaucoma or elevated intraocular pressure
08/21/2008WO2008100459A1 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists
08/21/2008WO2008099794A1 Fused ring compounds as partial agonists of ppar-gamma
08/21/2008WO2008099165A1 Piperidine derivatives and their use for treatment of ccr8 mediated diseases
08/21/2008WO2008099076A2 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof
08/21/2008WO2008099074A1 Phenyl- (4-phenyl-pyrimidin-2-yl) - amine derivatives as ikk inhibitors, preparation thereof, and pharmaceutical compositions thereof
08/21/2008WO2008099073A1 N, n' -2, 4-dianilinopyrimidines preparation and use thereof as ikk inhibitors preparation and teh pharmacuetical compositions thereof
08/21/2008WO2008099019A1 6-hydroxy-dibenzodiazepinones useful as hepatitis c virus inhibitors
08/21/2008WO2008098892A1 Fast dissociating dopamine 2 receptor antagonists
08/21/2008WO2008098859A1 Hcv polymerase inhibitors
08/21/2008WO2008034736A3 Oxindole derivatives as anticancer agents
08/21/2008WO2007139955A3 Triazole compounds that modulate hsp90 activity
08/21/2008US20080200693 Derivatives of Aryl (or Heteroaryl) Azolylcarbinols (in Particular Cizolirtin Citrate) for the Treatment of Opioid Addiction
08/21/2008US20080200524 Treating pain, inflammation and traumatic injury; using 2-pyridinyl-phenyl-4-amido-p-sulfono or sulfonamidobenzene derivatives
08/21/2008US20080200513 Pyridine N-Oxides As Antiviral Agents
08/21/2008US20080200509 Utilizing such as 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide against cancer growth
08/21/2008US20080200469 Phthalazinone derivatives
08/21/2008US20080200468 2-Substituted 5-Membered Heteroaryl Carboxylates as Hm74a Receptor Agonists
08/21/2008US20080200465 Antipathogenic benzamide compounds
08/21/2008US20080200455 1-Aryl- or 1-Alkylsulfonyl-Heterocyclylbenzazoles As 5-Hydroxytryptamine-6 Ligands
08/21/2008US20080200445 Heterocyclic aspartyl protease inhibitors
08/21/2008CA2679849A1 Functionally selective alpha2c adrenoreceptor agonists
08/21/2008CA2678191A1 Gamma-lactams for the treatment of glaucoma or elevated intraocular pressure
08/21/2008CA2678069A1 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists
08/21/2008CA2678036A1 Functionally selective alpha2c adrenoreceptor agonists
08/21/2008CA2677736A1 Fused ring compounds as partial agonists of ppar-gamma
08/21/2008CA2676906A1 Novel inhibitors hepatitis c virus replication
08/21/2008CA2674752A1 3,4-dihydropyrrolo[1,2-a]pyrazin-1-yl amines useful as fast dissociating dopamine 2 receptor antagonists
08/21/2008CA2673532A1 New phenyl-(4-phenyl-pyrimidin-2-yl)-amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
08/21/2008CA2672959A1 New n, n'- 2,4-dianilinopyrimidine derivatives, preparation thereof as drugs, pharmaceutical compositions essentially as ikk inhibitors
08/20/2008EP1958949A1 Therapeutic agent for corneal/conjuctival disease
08/20/2008EP1958948A1 Pyridazine compound and use thereof
08/20/2008EP1957484A2 Glucagon receptor antagonists, preparation and therapeutic uses
08/20/2008EP1957483A1 Novel vinylogous acids derivatives
08/20/2008EP1957466A1 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer
08/20/2008EP1957058A1 Compounds for the treatment of inflammatory disorders and microbial diseases
08/20/2008EP1670790B1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
08/20/2008EP1569647B1 Cyclohexyl compounds as ccr5 antagonists
08/20/2008EP1404653B1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion
08/20/2008EP1337251B1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
08/20/2008CN101248156A Novel materials for organic electroluminescent devices
08/20/2008CN101248063A Prodrugs of pyrazoline compounds, their preparation and use as medicaments
08/20/2008CN101248062A C-fms kinase inhibitors
08/20/2008CN101248059A Substituted amide derivatives as protein kinase inhibitors
08/20/2008CN101248049A 咪唑类lxr调节剂 Imidazole lxr modifier
08/20/2008CN101248048A Imidazole based LXR modulators